nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—lung cancer	0.241	1	CbGaD
Reboxetine—ABCB1—Topotecan—lung cancer	0.0349	0.0701	CbGbCtD
Reboxetine—ABCB1—Gefitinib—lung cancer	0.0319	0.0641	CbGbCtD
Reboxetine—CYP2D6—Gefitinib—lung cancer	0.0301	0.0604	CbGbCtD
Reboxetine—ABCB1—Vinorelbine—lung cancer	0.0246	0.0494	CbGbCtD
Reboxetine—CYP2D6—Vinorelbine—lung cancer	0.0232	0.0465	CbGbCtD
Reboxetine—CYP3A4—Topotecan—lung cancer	0.0209	0.042	CbGbCtD
Reboxetine—ABCB1—Crizotinib—lung cancer	0.0196	0.0393	CbGbCtD
Reboxetine—CYP3A4—Gefitinib—lung cancer	0.0191	0.0384	CbGbCtD
Reboxetine—ABCB1—Gemcitabine—lung cancer	0.0191	0.0384	CbGbCtD
Reboxetine—ABCB1—Erlotinib—lung cancer	0.0189	0.0379	CbGbCtD
Reboxetine—CYP3A4—Teniposide—lung cancer	0.0185	0.0372	CbGbCtD
Reboxetine—CYP2D6—Erlotinib—lung cancer	0.0178	0.0357	CbGbCtD
Reboxetine—ABCB1—Paclitaxel—lung cancer	0.0173	0.0347	CbGbCtD
Reboxetine—ABCB1—Irinotecan—lung cancer	0.017	0.0342	CbGbCtD
Reboxetine—ABCB1—Vinblastine—lung cancer	0.0152	0.0304	CbGbCtD
Reboxetine—CYP3A4—Vinorelbine—lung cancer	0.0147	0.0296	CbGbCtD
Reboxetine—CYP2D6—Vinblastine—lung cancer	0.0143	0.0287	CbGbCtD
Reboxetine—ABCB1—Cisplatin—lung cancer	0.0139	0.0279	CbGbCtD
Reboxetine—ABCB1—Etoposide—lung cancer	0.0137	0.0274	CbGbCtD
Reboxetine—ABCB1—Docetaxel—lung cancer	0.0125	0.0251	CbGbCtD
Reboxetine—CYP3A4—Crizotinib—lung cancer	0.0117	0.0235	CbGbCtD
Reboxetine—CYP3A4—Erlotinib—lung cancer	0.0113	0.0227	CbGbCtD
Reboxetine—CYP3A4—Paclitaxel—lung cancer	0.0104	0.0208	CbGbCtD
Reboxetine—CYP3A4—Irinotecan—lung cancer	0.0102	0.0205	CbGbCtD
Reboxetine—ABCB1—Doxorubicin—lung cancer	0.00931	0.0187	CbGbCtD
Reboxetine—CYP3A4—Vinblastine—lung cancer	0.00908	0.0182	CbGbCtD
Reboxetine—ABCB1—Methotrexate—lung cancer	0.00902	0.0181	CbGbCtD
Reboxetine—CYP2D6—Doxorubicin—lung cancer	0.00877	0.0176	CbGbCtD
Reboxetine—CYP3A4—Etoposide—lung cancer	0.00818	0.0164	CbGbCtD
Reboxetine—CYP3A4—Docetaxel—lung cancer	0.00748	0.015	CbGbCtD
Reboxetine—CYP3A4—Doxorubicin—lung cancer	0.00558	0.0112	CbGbCtD
Reboxetine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000119	0.000594	CcSEcCtD
Reboxetine—Anaemia—Docetaxel—lung cancer	0.000119	0.000593	CcSEcCtD
Reboxetine—Infestation NOS—Methotrexate—lung cancer	0.000119	0.000592	CcSEcCtD
Reboxetine—Infestation—Methotrexate—lung cancer	0.000119	0.000592	CcSEcCtD
Reboxetine—Anorexia—Paclitaxel—lung cancer	0.000118	0.000589	CcSEcCtD
Reboxetine—Hypotension—Etoposide—lung cancer	0.000118	0.000589	CcSEcCtD
Reboxetine—Muscular weakness—Doxorubicin—lung cancer	0.000118	0.000587	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000118	0.000587	CcSEcCtD
Reboxetine—Vomiting—Vinorelbine—lung cancer	0.000117	0.000584	CcSEcCtD
Reboxetine—Body temperature increased—Gemcitabine—lung cancer	0.000117	0.000584	CcSEcCtD
Reboxetine—Rash—Vinorelbine—lung cancer	0.000116	0.000579	CcSEcCtD
Reboxetine—Dermatitis—Vinorelbine—lung cancer	0.000116	0.000579	CcSEcCtD
Reboxetine—Hypotension—Paclitaxel—lung cancer	0.000116	0.000578	CcSEcCtD
Reboxetine—Headache—Vinorelbine—lung cancer	0.000115	0.000576	CcSEcCtD
Reboxetine—Syncope—Docetaxel—lung cancer	0.000115	0.000576	CcSEcCtD
Reboxetine—Conjunctivitis—Methotrexate—lung cancer	0.000115	0.000575	CcSEcCtD
Reboxetine—Influenza—Doxorubicin—lung cancer	0.000115	0.000575	CcSEcCtD
Reboxetine—Leukopenia—Docetaxel—lung cancer	0.000115	0.000575	CcSEcCtD
Reboxetine—Sweating—Methotrexate—lung cancer	0.000114	0.000568	CcSEcCtD
Reboxetine—Palpitations—Docetaxel—lung cancer	0.000114	0.000567	CcSEcCtD
Reboxetine—Feeling abnormal—Cisplatin—lung cancer	0.000114	0.000567	CcSEcCtD
Reboxetine—Paraesthesia—Etoposide—lung cancer	0.000114	0.000566	CcSEcCtD
Reboxetine—Loss of consciousness—Docetaxel—lung cancer	0.000113	0.000564	CcSEcCtD
Reboxetine—Dyspnoea—Etoposide—lung cancer	0.000113	0.000562	CcSEcCtD
Reboxetine—Somnolence—Etoposide—lung cancer	0.000112	0.00056	CcSEcCtD
Reboxetine—Insomnia—Paclitaxel—lung cancer	0.000112	0.000559	CcSEcCtD
Reboxetine—Epistaxis—Methotrexate—lung cancer	0.000112	0.000558	CcSEcCtD
Reboxetine—Hypersensitivity—Irinotecan—lung cancer	0.000112	0.000558	CcSEcCtD
Reboxetine—Paraesthesia—Paclitaxel—lung cancer	0.000111	0.000555	CcSEcCtD
Reboxetine—Hypertension—Docetaxel—lung cancer	0.000111	0.000554	CcSEcCtD
Reboxetine—Bronchitis—Doxorubicin—lung cancer	0.000111	0.000553	CcSEcCtD
Reboxetine—Dyspnoea—Paclitaxel—lung cancer	0.000111	0.000551	CcSEcCtD
Reboxetine—Somnolence—Paclitaxel—lung cancer	0.00011	0.000549	CcSEcCtD
Reboxetine—Decreased appetite—Etoposide—lung cancer	0.00011	0.000548	CcSEcCtD
Reboxetine—Chest pain—Docetaxel—lung cancer	0.00011	0.000546	CcSEcCtD
Reboxetine—Nausea—Vinorelbine—lung cancer	0.000109	0.000546	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Etoposide—lung cancer	0.000109	0.000544	CcSEcCtD
Reboxetine—Dyspepsia—Paclitaxel—lung cancer	0.000109	0.000544	CcSEcCtD
Reboxetine—Body temperature increased—Cisplatin—lung cancer	0.000109	0.000544	CcSEcCtD
Reboxetine—Asthenia—Irinotecan—lung cancer	0.000109	0.000544	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000109	0.000543	CcSEcCtD
Reboxetine—Constipation—Etoposide—lung cancer	0.000108	0.000539	CcSEcCtD
Reboxetine—Dysuria—Doxorubicin—lung cancer	0.000108	0.000538	CcSEcCtD
Reboxetine—Decreased appetite—Paclitaxel—lung cancer	0.000108	0.000537	CcSEcCtD
Reboxetine—Dry mouth—Docetaxel—lung cancer	0.000107	0.000534	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000107	0.000534	CcSEcCtD
Reboxetine—Pollakiuria—Doxorubicin—lung cancer	0.000107	0.000531	CcSEcCtD
Reboxetine—Asthenia—Gemcitabine—lung cancer	0.000106	0.00053	CcSEcCtD
Reboxetine—Constipation—Paclitaxel—lung cancer	0.000106	0.000529	CcSEcCtD
Reboxetine—Confusional state—Docetaxel—lung cancer	0.000106	0.000528	CcSEcCtD
Reboxetine—Pharyngitis—Methotrexate—lung cancer	0.000106	0.000527	CcSEcCtD
Reboxetine—Urinary tract disorder—Methotrexate—lung cancer	0.000105	0.000525	CcSEcCtD
Reboxetine—Urethral disorder—Methotrexate—lung cancer	0.000104	0.000521	CcSEcCtD
Reboxetine—Infection—Docetaxel—lung cancer	0.000104	0.00052	CcSEcCtD
Reboxetine—Weight decreased—Doxorubicin—lung cancer	0.000104	0.00052	CcSEcCtD
Reboxetine—Feeling abnormal—Etoposide—lung cancer	0.000104	0.000519	CcSEcCtD
Reboxetine—Hyperglycaemia—Doxorubicin—lung cancer	0.000104	0.000519	CcSEcCtD
Reboxetine—Diarrhoea—Irinotecan—lung cancer	0.000104	0.000518	CcSEcCtD
Reboxetine—Gastrointestinal pain—Etoposide—lung cancer	0.000103	0.000515	CcSEcCtD
Reboxetine—Shock—Docetaxel—lung cancer	0.000103	0.000515	CcSEcCtD
Reboxetine—Nervous system disorder—Docetaxel—lung cancer	0.000103	0.000514	CcSEcCtD
Reboxetine—Infestation—Doxorubicin—lung cancer	0.000103	0.000513	CcSEcCtD
Reboxetine—Infestation NOS—Doxorubicin—lung cancer	0.000103	0.000513	CcSEcCtD
Reboxetine—Visual impairment—Methotrexate—lung cancer	0.000103	0.000512	CcSEcCtD
Reboxetine—Tachycardia—Docetaxel—lung cancer	0.000103	0.000511	CcSEcCtD
Reboxetine—Feeling abnormal—Paclitaxel—lung cancer	0.000102	0.000509	CcSEcCtD
Reboxetine—Skin disorder—Docetaxel—lung cancer	0.000102	0.000509	CcSEcCtD
Reboxetine—Hypersensitivity—Cisplatin—lung cancer	0.000102	0.000507	CcSEcCtD
Reboxetine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000101	0.000505	CcSEcCtD
Reboxetine—Diarrhoea—Gemcitabine—lung cancer	0.000101	0.000505	CcSEcCtD
Reboxetine—Dizziness—Irinotecan—lung cancer	0.000101	0.000501	CcSEcCtD
Reboxetine—Urticaria—Etoposide—lung cancer	0.0001	0.000501	CcSEcCtD
Reboxetine—Anorexia—Docetaxel—lung cancer	0.0001	0.000499	CcSEcCtD
Reboxetine—Abdominal pain—Etoposide—lung cancer	9.99e-05	0.000498	CcSEcCtD
Reboxetine—Body temperature increased—Etoposide—lung cancer	9.99e-05	0.000498	CcSEcCtD
Reboxetine—Urinary tract infection—Doxorubicin—lung cancer	9.99e-05	0.000498	CcSEcCtD
Reboxetine—Conjunctivitis—Doxorubicin—lung cancer	9.99e-05	0.000498	CcSEcCtD
Reboxetine—Eye disorder—Methotrexate—lung cancer	9.96e-05	0.000497	CcSEcCtD
Reboxetine—Tinnitus—Methotrexate—lung cancer	9.94e-05	0.000495	CcSEcCtD
Reboxetine—Asthenia—Cisplatin—lung cancer	9.9e-05	0.000494	CcSEcCtD
Reboxetine—Cardiac disorder—Methotrexate—lung cancer	9.89e-05	0.000493	CcSEcCtD
Reboxetine—Sweating—Doxorubicin—lung cancer	9.86e-05	0.000491	CcSEcCtD
Reboxetine—Urticaria—Paclitaxel—lung cancer	9.85e-05	0.000491	CcSEcCtD
Reboxetine—Hypotension—Docetaxel—lung cancer	9.82e-05	0.000489	CcSEcCtD
Reboxetine—Body temperature increased—Paclitaxel—lung cancer	9.8e-05	0.000489	CcSEcCtD
Reboxetine—Abdominal pain—Paclitaxel—lung cancer	9.8e-05	0.000489	CcSEcCtD
Reboxetine—Epistaxis—Doxorubicin—lung cancer	9.7e-05	0.000483	CcSEcCtD
Reboxetine—Angiopathy—Methotrexate—lung cancer	9.67e-05	0.000482	CcSEcCtD
Reboxetine—Vomiting—Irinotecan—lung cancer	9.66e-05	0.000482	CcSEcCtD
Reboxetine—Sinusitis—Doxorubicin—lung cancer	9.65e-05	0.000481	CcSEcCtD
Reboxetine—Immune system disorder—Methotrexate—lung cancer	9.63e-05	0.00048	CcSEcCtD
Reboxetine—Mediastinal disorder—Methotrexate—lung cancer	9.61e-05	0.000479	CcSEcCtD
Reboxetine—Rash—Irinotecan—lung cancer	9.58e-05	0.000478	CcSEcCtD
Reboxetine—Dermatitis—Irinotecan—lung cancer	9.57e-05	0.000477	CcSEcCtD
Reboxetine—Chills—Methotrexate—lung cancer	9.56e-05	0.000477	CcSEcCtD
Reboxetine—Headache—Irinotecan—lung cancer	9.52e-05	0.000475	CcSEcCtD
Reboxetine—Insomnia—Docetaxel—lung cancer	9.5e-05	0.000474	CcSEcCtD
Reboxetine—Diarrhoea—Cisplatin—lung cancer	9.44e-05	0.000471	CcSEcCtD
Reboxetine—Paraesthesia—Docetaxel—lung cancer	9.43e-05	0.00047	CcSEcCtD
Reboxetine—Vomiting—Gemcitabine—lung cancer	9.41e-05	0.000469	CcSEcCtD
Reboxetine—Bradycardia—Doxorubicin—lung cancer	9.4e-05	0.000468	CcSEcCtD
Reboxetine—Dyspnoea—Docetaxel—lung cancer	9.37e-05	0.000467	CcSEcCtD
Reboxetine—Somnolence—Docetaxel—lung cancer	9.34e-05	0.000466	CcSEcCtD
Reboxetine—Mental disorder—Methotrexate—lung cancer	9.34e-05	0.000466	CcSEcCtD
Reboxetine—Rash—Gemcitabine—lung cancer	9.33e-05	0.000465	CcSEcCtD
Reboxetine—Dermatitis—Gemcitabine—lung cancer	9.33e-05	0.000465	CcSEcCtD
Reboxetine—Hypersensitivity—Etoposide—lung cancer	9.31e-05	0.000464	CcSEcCtD
Reboxetine—Malnutrition—Methotrexate—lung cancer	9.28e-05	0.000463	CcSEcCtD
Reboxetine—Headache—Gemcitabine—lung cancer	9.27e-05	0.000462	CcSEcCtD
Reboxetine—Rhinitis—Doxorubicin—lung cancer	9.25e-05	0.000461	CcSEcCtD
Reboxetine—Dyspepsia—Docetaxel—lung cancer	9.25e-05	0.000461	CcSEcCtD
Reboxetine—Pharyngitis—Doxorubicin—lung cancer	9.16e-05	0.000457	CcSEcCtD
Reboxetine—Decreased appetite—Docetaxel—lung cancer	9.13e-05	0.000455	CcSEcCtD
Reboxetine—Hypersensitivity—Paclitaxel—lung cancer	9.13e-05	0.000455	CcSEcCtD
Reboxetine—Urinary tract disorder—Doxorubicin—lung cancer	9.11e-05	0.000454	CcSEcCtD
Reboxetine—Dysgeusia—Methotrexate—lung cancer	9.09e-05	0.000453	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Docetaxel—lung cancer	9.07e-05	0.000452	CcSEcCtD
Reboxetine—Asthenia—Etoposide—lung cancer	9.07e-05	0.000452	CcSEcCtD
Reboxetine—Connective tissue disorder—Doxorubicin—lung cancer	9.07e-05	0.000452	CcSEcCtD
Reboxetine—Urethral disorder—Doxorubicin—lung cancer	9.05e-05	0.000451	CcSEcCtD
Reboxetine—Nausea—Irinotecan—lung cancer	9.03e-05	0.00045	CcSEcCtD
Reboxetine—Constipation—Docetaxel—lung cancer	8.98e-05	0.000448	CcSEcCtD
Reboxetine—Visual impairment—Doxorubicin—lung cancer	8.89e-05	0.000443	CcSEcCtD
Reboxetine—Asthenia—Paclitaxel—lung cancer	8.89e-05	0.000443	CcSEcCtD
Reboxetine—Nausea—Gemcitabine—lung cancer	8.79e-05	0.000438	CcSEcCtD
Reboxetine—Vomiting—Cisplatin—lung cancer	8.77e-05	0.000437	CcSEcCtD
Reboxetine—Rash—Cisplatin—lung cancer	8.7e-05	0.000434	CcSEcCtD
Reboxetine—Dermatitis—Cisplatin—lung cancer	8.69e-05	0.000433	CcSEcCtD
Reboxetine—Feeling abnormal—Docetaxel—lung cancer	8.66e-05	0.000432	CcSEcCtD
Reboxetine—Diarrhoea—Etoposide—lung cancer	8.65e-05	0.000431	CcSEcCtD
Reboxetine—Eye disorder—Doxorubicin—lung cancer	8.63e-05	0.00043	CcSEcCtD
Reboxetine—Ill-defined disorder—Methotrexate—lung cancer	8.61e-05	0.000429	CcSEcCtD
Reboxetine—Tinnitus—Doxorubicin—lung cancer	8.61e-05	0.000429	CcSEcCtD
Reboxetine—Gastrointestinal pain—Docetaxel—lung cancer	8.59e-05	0.000428	CcSEcCtD
Reboxetine—Anaemia—Methotrexate—lung cancer	8.58e-05	0.000428	CcSEcCtD
Reboxetine—Cardiac disorder—Doxorubicin—lung cancer	8.57e-05	0.000427	CcSEcCtD
Reboxetine—Diarrhoea—Paclitaxel—lung cancer	8.48e-05	0.000423	CcSEcCtD
Reboxetine—Angiopathy—Doxorubicin—lung cancer	8.37e-05	0.000418	CcSEcCtD
Reboxetine—Malaise—Methotrexate—lung cancer	8.37e-05	0.000417	CcSEcCtD
Reboxetine—Dizziness—Etoposide—lung cancer	8.36e-05	0.000417	CcSEcCtD
Reboxetine—Immune system disorder—Doxorubicin—lung cancer	8.34e-05	0.000416	CcSEcCtD
Reboxetine—Vertigo—Methotrexate—lung cancer	8.34e-05	0.000416	CcSEcCtD
Reboxetine—Mediastinal disorder—Doxorubicin—lung cancer	8.32e-05	0.000415	CcSEcCtD
Reboxetine—Abdominal pain—Docetaxel—lung cancer	8.31e-05	0.000414	CcSEcCtD
Reboxetine—Body temperature increased—Docetaxel—lung cancer	8.31e-05	0.000414	CcSEcCtD
Reboxetine—Leukopenia—Methotrexate—lung cancer	8.31e-05	0.000414	CcSEcCtD
Reboxetine—Chills—Doxorubicin—lung cancer	8.28e-05	0.000413	CcSEcCtD
Reboxetine—Dizziness—Paclitaxel—lung cancer	8.2e-05	0.000409	CcSEcCtD
Reboxetine—Nausea—Cisplatin—lung cancer	8.2e-05	0.000409	CcSEcCtD
Reboxetine—Mental disorder—Doxorubicin—lung cancer	8.09e-05	0.000403	CcSEcCtD
Reboxetine—Vomiting—Etoposide—lung cancer	8.04e-05	0.000401	CcSEcCtD
Reboxetine—Malnutrition—Doxorubicin—lung cancer	8.03e-05	0.000401	CcSEcCtD
Reboxetine—Rash—Etoposide—lung cancer	7.97e-05	0.000397	CcSEcCtD
Reboxetine—Dermatitis—Etoposide—lung cancer	7.96e-05	0.000397	CcSEcCtD
Reboxetine—Headache—Etoposide—lung cancer	7.92e-05	0.000395	CcSEcCtD
Reboxetine—Chest pain—Methotrexate—lung cancer	7.9e-05	0.000394	CcSEcCtD
Reboxetine—Tension—Doxorubicin—lung cancer	7.88e-05	0.000393	CcSEcCtD
Reboxetine—Vomiting—Paclitaxel—lung cancer	7.88e-05	0.000393	CcSEcCtD
Reboxetine—Dysgeusia—Doxorubicin—lung cancer	7.87e-05	0.000392	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.84e-05	0.000391	CcSEcCtD
Reboxetine—Rash—Paclitaxel—lung cancer	7.82e-05	0.00039	CcSEcCtD
Reboxetine—Dermatitis—Paclitaxel—lung cancer	7.81e-05	0.000389	CcSEcCtD
Reboxetine—Discomfort—Methotrexate—lung cancer	7.8e-05	0.000389	CcSEcCtD
Reboxetine—Nervousness—Doxorubicin—lung cancer	7.8e-05	0.000389	CcSEcCtD
Reboxetine—Headache—Paclitaxel—lung cancer	7.77e-05	0.000387	CcSEcCtD
Reboxetine—Hypersensitivity—Docetaxel—lung cancer	7.74e-05	0.000386	CcSEcCtD
Reboxetine—Confusional state—Methotrexate—lung cancer	7.64e-05	0.000381	CcSEcCtD
Reboxetine—Asthenia—Docetaxel—lung cancer	7.54e-05	0.000376	CcSEcCtD
Reboxetine—Infection—Methotrexate—lung cancer	7.52e-05	0.000375	CcSEcCtD
Reboxetine—Nausea—Etoposide—lung cancer	7.51e-05	0.000374	CcSEcCtD
Reboxetine—Ill-defined disorder—Doxorubicin—lung cancer	7.45e-05	0.000372	CcSEcCtD
Reboxetine—Nervous system disorder—Methotrexate—lung cancer	7.43e-05	0.00037	CcSEcCtD
Reboxetine—Anaemia—Doxorubicin—lung cancer	7.43e-05	0.00037	CcSEcCtD
Reboxetine—Agitation—Doxorubicin—lung cancer	7.38e-05	0.000368	CcSEcCtD
Reboxetine—Nausea—Paclitaxel—lung cancer	7.36e-05	0.000367	CcSEcCtD
Reboxetine—Skin disorder—Methotrexate—lung cancer	7.36e-05	0.000367	CcSEcCtD
Reboxetine—Hyperhidrosis—Methotrexate—lung cancer	7.32e-05	0.000365	CcSEcCtD
Reboxetine—Malaise—Doxorubicin—lung cancer	7.25e-05	0.000361	CcSEcCtD
Reboxetine—Vertigo—Doxorubicin—lung cancer	7.22e-05	0.00036	CcSEcCtD
Reboxetine—Anorexia—Methotrexate—lung cancer	7.22e-05	0.00036	CcSEcCtD
Reboxetine—Syncope—Doxorubicin—lung cancer	7.21e-05	0.000359	CcSEcCtD
Reboxetine—Leukopenia—Doxorubicin—lung cancer	7.19e-05	0.000359	CcSEcCtD
Reboxetine—Diarrhoea—Docetaxel—lung cancer	7.19e-05	0.000358	CcSEcCtD
Reboxetine—Palpitations—Doxorubicin—lung cancer	7.1e-05	0.000354	CcSEcCtD
Reboxetine—Hypotension—Methotrexate—lung cancer	7.08e-05	0.000353	CcSEcCtD
Reboxetine—Loss of consciousness—Doxorubicin—lung cancer	7.06e-05	0.000352	CcSEcCtD
Reboxetine—Dizziness—Docetaxel—lung cancer	6.95e-05	0.000346	CcSEcCtD
Reboxetine—Hypertension—Doxorubicin—lung cancer	6.94e-05	0.000346	CcSEcCtD
Reboxetine—Insomnia—Methotrexate—lung cancer	6.85e-05	0.000341	CcSEcCtD
Reboxetine—Chest pain—Doxorubicin—lung cancer	6.84e-05	0.000341	CcSEcCtD
Reboxetine—Anxiety—Doxorubicin—lung cancer	6.82e-05	0.00034	CcSEcCtD
Reboxetine—Paraesthesia—Methotrexate—lung cancer	6.8e-05	0.000339	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.79e-05	0.000339	CcSEcCtD
Reboxetine—Discomfort—Doxorubicin—lung cancer	6.76e-05	0.000337	CcSEcCtD
Reboxetine—Dyspnoea—Methotrexate—lung cancer	6.75e-05	0.000337	CcSEcCtD
Reboxetine—Somnolence—Methotrexate—lung cancer	6.73e-05	0.000336	CcSEcCtD
Reboxetine—Dry mouth—Doxorubicin—lung cancer	6.69e-05	0.000334	CcSEcCtD
Reboxetine—Vomiting—Docetaxel—lung cancer	6.68e-05	0.000333	CcSEcCtD
Reboxetine—Dyspepsia—Methotrexate—lung cancer	6.67e-05	0.000332	CcSEcCtD
Reboxetine—Rash—Docetaxel—lung cancer	6.62e-05	0.00033	CcSEcCtD
Reboxetine—Dermatitis—Docetaxel—lung cancer	6.62e-05	0.00033	CcSEcCtD
Reboxetine—Confusional state—Doxorubicin—lung cancer	6.61e-05	0.00033	CcSEcCtD
Reboxetine—Decreased appetite—Methotrexate—lung cancer	6.58e-05	0.000328	CcSEcCtD
Reboxetine—Headache—Docetaxel—lung cancer	6.58e-05	0.000328	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Methotrexate—lung cancer	6.54e-05	0.000326	CcSEcCtD
Reboxetine—Infection—Doxorubicin—lung cancer	6.51e-05	0.000325	CcSEcCtD
Reboxetine—Shock—Doxorubicin—lung cancer	6.45e-05	0.000322	CcSEcCtD
Reboxetine—Nervous system disorder—Doxorubicin—lung cancer	6.43e-05	0.000321	CcSEcCtD
Reboxetine—Tachycardia—Doxorubicin—lung cancer	6.4e-05	0.000319	CcSEcCtD
Reboxetine—Skin disorder—Doxorubicin—lung cancer	6.37e-05	0.000318	CcSEcCtD
Reboxetine—Hyperhidrosis—Doxorubicin—lung cancer	6.34e-05	0.000316	CcSEcCtD
Reboxetine—Anorexia—Doxorubicin—lung cancer	6.25e-05	0.000312	CcSEcCtD
Reboxetine—Nausea—Docetaxel—lung cancer	6.24e-05	0.000311	CcSEcCtD
Reboxetine—Feeling abnormal—Methotrexate—lung cancer	6.24e-05	0.000311	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methotrexate—lung cancer	6.19e-05	0.000309	CcSEcCtD
Reboxetine—Hypotension—Doxorubicin—lung cancer	6.13e-05	0.000305	CcSEcCtD
Reboxetine—Urticaria—Methotrexate—lung cancer	6.02e-05	0.0003	CcSEcCtD
Reboxetine—Abdominal pain—Methotrexate—lung cancer	5.99e-05	0.000298	CcSEcCtD
Reboxetine—Body temperature increased—Methotrexate—lung cancer	5.99e-05	0.000298	CcSEcCtD
Reboxetine—Insomnia—Doxorubicin—lung cancer	5.93e-05	0.000296	CcSEcCtD
Reboxetine—Paraesthesia—Doxorubicin—lung cancer	5.89e-05	0.000294	CcSEcCtD
Reboxetine—Dyspnoea—Doxorubicin—lung cancer	5.85e-05	0.000291	CcSEcCtD
Reboxetine—Somnolence—Doxorubicin—lung cancer	5.83e-05	0.000291	CcSEcCtD
Reboxetine—Dyspepsia—Doxorubicin—lung cancer	5.77e-05	0.000288	CcSEcCtD
Reboxetine—Decreased appetite—Doxorubicin—lung cancer	5.7e-05	0.000284	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Doxorubicin—lung cancer	5.66e-05	0.000282	CcSEcCtD
Reboxetine—Constipation—Doxorubicin—lung cancer	5.61e-05	0.00028	CcSEcCtD
Reboxetine—Hypersensitivity—Methotrexate—lung cancer	5.58e-05	0.000278	CcSEcCtD
Reboxetine—Asthenia—Methotrexate—lung cancer	5.43e-05	0.000271	CcSEcCtD
Reboxetine—Feeling abnormal—Doxorubicin—lung cancer	5.4e-05	0.000269	CcSEcCtD
Reboxetine—Gastrointestinal pain—Doxorubicin—lung cancer	5.36e-05	0.000267	CcSEcCtD
Reboxetine—Urticaria—Doxorubicin—lung cancer	5.21e-05	0.00026	CcSEcCtD
Reboxetine—Body temperature increased—Doxorubicin—lung cancer	5.18e-05	0.000258	CcSEcCtD
Reboxetine—Abdominal pain—Doxorubicin—lung cancer	5.18e-05	0.000258	CcSEcCtD
Reboxetine—Diarrhoea—Methotrexate—lung cancer	5.18e-05	0.000258	CcSEcCtD
Reboxetine—Dizziness—Methotrexate—lung cancer	5.01e-05	0.00025	CcSEcCtD
Reboxetine—Hypersensitivity—Doxorubicin—lung cancer	4.83e-05	0.000241	CcSEcCtD
Reboxetine—Vomiting—Methotrexate—lung cancer	4.81e-05	0.00024	CcSEcCtD
Reboxetine—Rash—Methotrexate—lung cancer	4.77e-05	0.000238	CcSEcCtD
Reboxetine—Dermatitis—Methotrexate—lung cancer	4.77e-05	0.000238	CcSEcCtD
Reboxetine—Headache—Methotrexate—lung cancer	4.74e-05	0.000237	CcSEcCtD
Reboxetine—Asthenia—Doxorubicin—lung cancer	4.7e-05	0.000235	CcSEcCtD
Reboxetine—Nausea—Methotrexate—lung cancer	4.5e-05	0.000224	CcSEcCtD
Reboxetine—Diarrhoea—Doxorubicin—lung cancer	4.49e-05	0.000224	CcSEcCtD
Reboxetine—Dizziness—Doxorubicin—lung cancer	4.34e-05	0.000216	CcSEcCtD
Reboxetine—Vomiting—Doxorubicin—lung cancer	4.17e-05	0.000208	CcSEcCtD
Reboxetine—Rash—Doxorubicin—lung cancer	4.13e-05	0.000206	CcSEcCtD
Reboxetine—Dermatitis—Doxorubicin—lung cancer	4.13e-05	0.000206	CcSEcCtD
Reboxetine—Headache—Doxorubicin—lung cancer	4.11e-05	0.000205	CcSEcCtD
Reboxetine—Nausea—Doxorubicin—lung cancer	3.89e-05	0.000194	CcSEcCtD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	2.06e-05	0.000341	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.05e-05	0.00034	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.05e-05	0.000339	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTMR3—lung cancer	2.03e-05	0.000336	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFC—lung cancer	2e-05	0.000332	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2A7—lung cancer	2e-05	0.000332	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.99e-05	0.000329	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.98e-05	0.000328	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PGAM1—lung cancer	1.98e-05	0.000327	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SDC4—lung cancer	1.96e-05	0.000324	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ATP5H—lung cancer	1.91e-05	0.000317	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—POMC—lung cancer	1.91e-05	0.000316	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADCY1—lung cancer	1.89e-05	0.000313	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.89e-05	0.000313	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP2A7—lung cancer	1.89e-05	0.000312	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SDC4—lung cancer	1.85e-05	0.000306	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PPP2R1B—lung cancer	1.84e-05	0.000305	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SMARCA4—lung cancer	1.84e-05	0.000305	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.84e-05	0.000304	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.79e-05	0.000296	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—RRM1—lung cancer	1.78e-05	0.000295	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTA3—lung cancer	1.78e-05	0.000295	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HSPB1—lung cancer	1.78e-05	0.000295	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTHLH—lung cancer	1.76e-05	0.000291	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLBD1—lung cancer	1.71e-05	0.000283	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.7e-05	0.000282	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.69e-05	0.00028	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTA3—lung cancer	1.68e-05	0.000278	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—RRM1—lung cancer	1.68e-05	0.000278	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—B4GALT5—lung cancer	1.68e-05	0.000278	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ANXA1—lung cancer	1.65e-05	0.000274	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.65e-05	0.000273	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTA4—lung cancer	1.63e-05	0.00027	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.61e-05	0.000267	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FLT1—lung cancer	1.6e-05	0.000265	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTA2—lung cancer	1.59e-05	0.000263	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CG—lung cancer	1.59e-05	0.000263	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—B4GALT5—lung cancer	1.58e-05	0.000262	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APP—lung cancer	1.57e-05	0.00026	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH3—lung cancer	1.57e-05	0.00026	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HSD17B10—lung cancer	1.56e-05	0.000258	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF9—lung cancer	1.56e-05	0.000258	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTA4—lung cancer	1.54e-05	0.000255	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTA1—lung cancer	1.53e-05	0.000254	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.52e-05	0.000252	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCC3—lung cancer	1.52e-05	0.000251	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—POMC—lung cancer	1.51e-05	0.00025	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTA2—lung cancer	1.5e-05	0.000248	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—JUNB—lung cancer	1.49e-05	0.000246	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKR1C1—lung cancer	1.47e-05	0.000243	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CKB—lung cancer	1.45e-05	0.00024	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTA1—lung cancer	1.45e-05	0.000239	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CG—lung cancer	1.44e-05	0.000239	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCC3—lung cancer	1.43e-05	0.000237	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—UGT1A1—lung cancer	1.43e-05	0.000236	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.4e-05	0.000231	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CD—lung cancer	1.4e-05	0.000231	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKR1C1—lung cancer	1.38e-05	0.000229	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GNG11—lung cancer	1.38e-05	0.000228	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—POMC—lung cancer	1.37e-05	0.000227	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CNDP2—lung cancer	1.36e-05	0.000226	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTM2—lung cancer	1.36e-05	0.000226	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.35e-05	0.000224	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—STK11—lung cancer	1.35e-05	0.000223	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—UGT1A1—lung cancer	1.34e-05	0.000223	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6R—lung cancer	1.34e-05	0.000222	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTMR3—lung cancer	1.33e-05	0.00022	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALDOA—lung cancer	1.31e-05	0.000217	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FOXO3—lung cancer	1.3e-05	0.000216	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.3e-05	0.000215	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GNG11—lung cancer	1.3e-05	0.000215	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PGAM1—lung cancer	1.29e-05	0.000214	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAP2K1—lung cancer	1.28e-05	0.000211	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NCOA3—lung cancer	1.27e-05	0.000211	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CD—lung cancer	1.27e-05	0.00021	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADCY1—lung cancer	1.24e-05	0.000205	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCG2—lung cancer	1.24e-05	0.000205	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALDOA—lung cancer	1.23e-05	0.000204	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2A7—lung cancer	1.23e-05	0.000204	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AVP—lung cancer	1.22e-05	0.000202	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CB—lung cancer	1.22e-05	0.000201	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ENO2—lung cancer	1.21e-05	0.000201	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HPGDS—lung cancer	1.21e-05	0.000201	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SDC4—lung cancer	1.21e-05	0.0002	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPP2R1B—lung cancer	1.21e-05	0.0002	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NCOA3—lung cancer	1.2e-05	0.000198	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTT1—lung cancer	1.18e-05	0.000195	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1R—lung cancer	1.17e-05	0.000194	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CXCL8—lung cancer	1.17e-05	0.000194	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADCY1—lung cancer	1.17e-05	0.000193	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCG2—lung cancer	1.17e-05	0.000193	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GCLC—lung cancer	1.16e-05	0.000193	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2A6—lung cancer	1.16e-05	0.000193	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HES1—lung cancer	1.15e-05	0.000191	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ENO2—lung cancer	1.14e-05	0.000189	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HPGDS—lung cancer	1.14e-05	0.000189	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.14e-05	0.000189	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.14e-05	0.000188	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—RAF1—lung cancer	1.13e-05	0.000187	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—IL2—lung cancer	1.12e-05	0.000185	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTT1—lung cancer	1.11e-05	0.000184	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CB—lung cancer	1.1e-05	0.000183	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ENO1—lung cancer	1.1e-05	0.000183	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.1e-05	0.000182	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTA3—lung cancer	1.1e-05	0.000182	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—RRM1—lung cancer	1.1e-05	0.000182	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP2A6—lung cancer	1.1e-05	0.000181	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GCLC—lung cancer	1.1e-05	0.000181	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCL8—lung cancer	1.06e-05	0.000176	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ERBB3—lung cancer	1.05e-05	0.000175	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ENO1—lung cancer	1.04e-05	0.000172	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.03e-05	0.000171	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.03e-05	0.000171	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL2—lung cancer	1.01e-05	0.000168	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TERT—lung cancer	1.01e-05	0.000167	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTA4—lung cancer	1.01e-05	0.000166	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2E1—lung cancer	9.89e-06	0.000164	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGFR1—lung cancer	9.81e-06	0.000163	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTA2—lung cancer	9.8e-06	0.000162	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NQO1—lung cancer	9.78e-06	0.000162	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HIF1A—lung cancer	9.67e-06	0.00016	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTA1—lung cancer	9.45e-06	0.000157	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCC3—lung cancer	9.35e-06	0.000155	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOA1—lung cancer	9.33e-06	0.000154	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	9.32e-06	0.000154	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP2E1—lung cancer	9.32e-06	0.000154	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KDR—lung cancer	9.24e-06	0.000153	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NQO1—lung cancer	9.21e-06	0.000153	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKR1C1—lung cancer	9.05e-06	0.00015	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—STK11—lung cancer	8.81e-06	0.000146	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—UGT1A1—lung cancer	8.79e-06	0.000146	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KIT—lung cancer	8.52e-06	0.000141	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APC—lung cancer	8.52e-06	0.000141	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CG—lung cancer	8.52e-06	0.000141	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—NRAS—lung cancer	8.52e-06	0.000141	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GNG11—lung cancer	8.47e-06	0.00014	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EGF—lung cancer	8.42e-06	0.000139	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—STK11—lung cancer	8.3e-06	0.000138	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAPK3—lung cancer	8.16e-06	0.000135	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTP1—lung cancer	8.15e-06	0.000135	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—POMC—lung cancer	8.11e-06	0.000134	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDOA—lung cancer	8.07e-06	0.000134	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—BRAF—lung cancer	8e-06	0.000133	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CAT—lung cancer	7.93e-06	0.000131	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6R—lung cancer	7.91e-06	0.000131	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CREBBP—lung cancer	7.9e-06	0.000131	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCOA3—lung cancer	7.83e-06	0.00013	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—EGFR—lung cancer	7.76e-06	0.000128	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTP1—lung cancer	7.68e-06	0.000127	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADCY1—lung cancer	7.62e-06	0.000126	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCG2—lung cancer	7.62e-06	0.000126	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TYMS—lung cancer	7.58e-06	0.000126	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAP2K1—lung cancer	7.54e-06	0.000125	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTM1—lung cancer	7.49e-06	0.000124	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CD—lung cancer	7.49e-06	0.000124	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CAT—lung cancer	7.48e-06	0.000124	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ENO2—lung cancer	7.47e-06	0.000124	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HPGDS—lung cancer	7.47e-06	0.000124	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.42e-06	0.000123	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CA—lung cancer	7.41e-06	0.000123	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—KRAS—lung cancer	7.33e-06	0.000121	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCB1—lung cancer	7.27e-06	0.00012	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTT1—lung cancer	7.25e-06	0.00012	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GCLC—lung cancer	7.16e-06	0.000119	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2A6—lung cancer	7.16e-06	0.000119	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TYMS—lung cancer	7.14e-06	0.000118	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP1A1—lung cancer	7.1e-06	0.000118	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTM1—lung cancer	7.06e-06	0.000117	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ERCC2—lung cancer	7.04e-06	0.000117	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ENO1—lung cancer	6.79e-06	0.000112	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CA—lung cancer	6.73e-06	0.000112	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MDM2—lung cancer	6.71e-06	0.000111	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP1A1—lung cancer	6.69e-06	0.000111	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RAF1—lung cancer	6.68e-06	0.000111	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ERCC2—lung cancer	6.64e-06	0.00011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ERBB2—lung cancer	6.61e-06	0.00011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CB—lung cancer	6.52e-06	0.000108	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MTOR—lung cancer	6.52e-06	0.000108	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL8—lung cancer	6.27e-06	0.000104	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HRAS—lung cancer	6.23e-06	0.000103	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOA1—lung cancer	6.09e-06	0.000101	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2E1—lung cancer	6.09e-06	0.000101	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT1—lung cancer	6.06e-06	0.0001	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NQO1—lung cancer	6.02e-06	9.97e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASP3—lung cancer	6e-06	9.94e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL2—lung cancer	5.99e-06	9.92e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6—lung cancer	5.96e-06	9.87e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCND1—lung cancer	5.84e-06	9.67e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—JUN—lung cancer	5.83e-06	9.65e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOA1—lung cancer	5.74e-06	9.51e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP9—lung cancer	5.67e-06	9.39e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN1A—lung cancer	5.65e-06	9.36e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTEN—lung cancer	5.64e-06	9.34e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CG—lung cancer	5.56e-06	9.21e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT1—lung cancer	5.5e-06	9.11e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—STK11—lung cancer	5.43e-06	8.99e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EP300—lung cancer	5.38e-06	8.91e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—POMC—lung cancer	5.3e-06	8.77e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CG—lung cancer	5.24e-06	8.68e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SRC—lung cancer	5.23e-06	8.66e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CREBBP—lung cancer	5.16e-06	8.54e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFA—lung cancer	5.09e-06	8.43e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—STAT3—lung cancer	5.04e-06	8.35e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NRAS—lung cancer	5.03e-06	8.33e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTP1—lung cancer	5.02e-06	8.32e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—POMC—lung cancer	4.99e-06	8.26e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CD—lung cancer	4.89e-06	8.1e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CAT—lung cancer	4.89e-06	8.1e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CREBBP—lung cancer	4.86e-06	8.05e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALB—lung cancer	4.83e-06	8e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK3—lung cancer	4.82e-06	7.98e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCB1—lung cancer	4.76e-06	7.87e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MYC—lung cancer	4.69e-06	7.76e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TYMS—lung cancer	4.67e-06	7.73e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTM1—lung cancer	4.62e-06	7.64e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CD—lung cancer	4.61e-06	7.63e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EGFR—lung cancer	4.58e-06	7.59e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALB—lung cancer	4.55e-06	7.53e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP1A1—lung cancer	4.38e-06	7.25e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ERCC2—lung cancer	4.34e-06	7.19e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KRAS—lung cancer	4.33e-06	7.17e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CB—lung cancer	4.26e-06	7.06e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS2—lung cancer	4.22e-06	7e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CB—lung cancer	4.02e-06	6.65e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS2—lung cancer	3.98e-06	6.59e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	3.98e-06	6.59e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TP53—lung cancer	3.85e-06	6.37e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOA1—lung cancer	3.75e-06	6.22e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTEN—lung cancer	3.68e-06	6.1e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HRAS—lung cancer	3.68e-06	6.09e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6—lung cancer	3.52e-06	5.83e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—EP300—lung cancer	3.51e-06	5.82e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTEN—lung cancer	3.47e-06	5.75e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CG—lung cancer	3.43e-06	5.68e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—EP300—lung cancer	3.31e-06	5.48e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—POMC—lung cancer	3.26e-06	5.4e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT1—lung cancer	3.25e-06	5.38e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CREBBP—lung cancer	3.18e-06	5.26e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CD—lung cancer	3.01e-06	4.99e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALB—lung cancer	2.97e-06	4.93e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.63e-06	4.35e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS2—lung cancer	2.6e-06	4.31e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CA—lung cancer	2.6e-06	4.3e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CA—lung cancer	2.45e-06	4.06e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTEN—lung cancer	2.27e-06	3.76e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—EP300—lung cancer	2.16e-06	3.58e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKT1—lung cancer	2.12e-06	3.52e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKT1—lung cancer	2e-06	3.31e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.6e-06	2.65e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKT1—lung cancer	1.31e-06	2.17e-05	CbGpPWpGaD
